Provided by Tiger Trade Technology Pte. Ltd.

Ashland

50.45
+0.52501.05%
Volume:36.70K
Turnover:1.84M
Market Cap:2.31B
PE:-3.34
High:50.46
Open:49.35
Low:49.30
Close:49.92
52wk High:65.65
52wk Low:45.21
Shares:45.76M
Float Shares:41.77M
Volume Ratio:0.35
T/O Rate:0.09%
Dividend:1.65
Dividend Rate:3.27%
EPS(TTM):-15.1257
EPS(LYR):-18.3696
ROE:-29.98%
ROA:2.09%
PB:1.23
PE(LYR):-2.75

Loading ...

U.S. RESEARCH ROUNDUP- Ametek, Coca-Cola, Pepsico

Reuters
·
Feb 04

Stock Track | Ashland Plummets 5.35% Intraday Following Q1 Earnings Report Showing Lower Income

Stock Track
·
Feb 03

Ashland meldet im ersten Quartal (Q1) einen Free Cash Flow von 26,00 Mio. USD nach zuvor minus 26,00 Mio. USD

Reuters
·
Feb 03

Ashland Logs Lower Revenue On Volume Declines

Dow Jones
·
Feb 03

BRIEF-Ashland Inc Updated Outlook Includes About $11M In Temporary Impacts From Calvert City Startup Delay,Recent Weather Disruptions, All Isolated To Q2

Reuters
·
Feb 03

BRIEF-Ashland Reports First Quarter Fiscal 2026 Results And Narrows Full-Year Outlook

Reuters
·
Feb 03

Ashland Q1 revenue misses expectations, hurt by Avoca divestiture

Reuters
·
Feb 03

Ashland affirms FY6 revenue view of $1.835B-$1.905B

TIPRANKS
·
Feb 03

Ashland Inc Outlook FY Adj EPS Excluding Intangibles Amortization Double Digit Plus Growth

THOMSON REUTERS
·
Feb 03

Ashland Inc: Expect Year to Follow Typical Seasonal Cadence With Stronger Performance in H2 as Commercial Activity and Operational Efficiencies Build

THOMSON REUTERS
·
Feb 03

Ashland Q1 Adj. EPS $0.26, Inline, Sales $386.000M Miss $402.011M Estimate

Benzinga
·
Feb 03

BRIEF-Ashland Q1 Revenue USD 386 Million Vs. IBES Estimate USD 402 Million

Reuters
·
Feb 03

Ashland Inc. Q1 net loss at USD 12 million, down from profit, as sales fall 5 percent to USD 386 million

Reuters
·
Feb 03

Ashland Q1 Net Income USD -12 Million

THOMSON REUTERS
·
Feb 03

Press Release: Ashland reports first quarter fiscal 2026 results and narrows full-year outlook

Dow Jones
·
Feb 03

UBS Keeps Their Buy Rating on Ashland (ASH)

TIPRANKS
·
Feb 03

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 02

A Look At Ashland (ASH) Valuation As Shares Rebound Over The Past Three Months

Simply Wall St.
·
Jan 30

Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update

GlobeNewswire
·
Jan 29

Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201

GlobeNewswire
·
Jan 28